Literature DB >> 11588424

Amniotic membrane transplantation in infectious corneal ulcer.

J S Kim1, J C Kim, T W Hahn, W C Park.   

Abstract

PURPOSE: To evaluate the efficacy of amniotic membrane transplantation in the management of treated infectious corneal ulcer in which inflammatory reactions were responsible for corneal damage.
METHOD: A prospective study of 21 consecutive eyes (21 patients) was performed. Sufficient antibacterial, antifungal, or antiviral agents were applied to eradicate causative organisms before permanent or temporary amniotic membrane transplantation, or a combination of the two in few patients. The amniotic membrane was soaked in antiinfective agents before transplantation in all cases.
RESULTS: After amniotic membrane transplantation, follow-up times ranged from 4 to 28 months (mean, 18 months). Clinical indications included Staphylococcus species (four cases), Pseudomonas species (five cases), Acanthamoeba species (three cases), fungus (two cases), and herpesvirus (seven cases). The corneal surface was healed successfully and recurrences of microbial infection were not noted in any case. Visual acuity was improved in cases that were nonscarring or after additional penetrating keratoplasty.
CONCLUSION: Amniotic membrane transplantation seems to be a useful adjunctive surgical procedure for the management of infectious corneal ulcer by promoting wound healing and reducing inflammation.

Entities:  

Mesh:

Year:  2001        PMID: 11588424     DOI: 10.1097/00003226-200110000-00010

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  27 in total

1.  Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate.

Authors:  Juan Ye; Koung Hoon Kook; Ke Yao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

2.  Amniotic membrane covering promotes healing of cornea epithelium and improves visual acuity after debridement for fungal keratitis.

Authors:  Bo Zeng; Ping Wang; Ling-Juan Xu; Xin-Yu Li; Hong Zhang; Gui-Gang Li
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Treatment of an 8-mm myxoma using acellular corneal tissue.

Authors:  Kyung Sup Lim; Sung Wook Wee; Jae Chan Kim
Journal:  Korean J Ophthalmol       Date:  2014-01-21

4.  Excisional keratectomy combined with focal cryotherapy and amniotic membrane inlay for recalcitrant filamentary fungal keratitis: A retrospective comparative clinical data analysis.

Authors:  Yingxin Chen; Minghong Gao; Joshua K Duncan; Di Ran; Denise J Roe; Michael W Belin; Mingwu Wang
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

5.  Self-Retained Amniotic Membrane Combined With Antiviral Therapy for Herpetic Epithelial Keratitis.

Authors:  Anny M S Cheng; Scheffer C G Tseng
Journal:  Cornea       Date:  2017-11       Impact factor: 2.651

6.  Sutureless amniotic membrane transplantation for severe bacterial keratitis.

Authors:  Hosam Sheha; Lingyi Liang; Jianjing Li; Scheffer C G Tseng
Journal:  Cornea       Date:  2009-12       Impact factor: 2.651

Review 7.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Canine amniotic membrane transplantation for corneal reconstruction after the excision of dermoids in dogs.

Authors:  Marissak Kalpravidh; Pranee Tuntivanich; Simon Vongsakul; Sudson Sirivaidyapong
Journal:  Vet Res Commun       Date:  2009-09-17       Impact factor: 2.459

9.  Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation.

Authors:  A Heiligenhaus; H Li; E E Hernandez Galindo; J M Koch; K-P Steuhl; D Meller
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

10.  A case of amniotic membrane transplantation in non-healing Nocardia asteroides keratitis.

Authors:  Firoozeh Rahimi; Masood Aghsaie Fard; Reza Soltani Mogaddam
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.